Retraction

LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis

Paper Information

Record ID:
25843
Publication Date:
December 02, 2019
Retraction Date:
February 01, 2021 (4.8 years years ago)
Article Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed

Citations (6)

6
Total Citations
2
Post-Retraction
(33.3%)
3
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
1028 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Comprehensive analysis of cuproptosis-associated LncRNAs predictive value and related CeRNA network in acute myeloid leukemia
Chun Cao, Teng Wang, Yun Luo et al. (6 authors)
Heliyon Open Access
Published: Nov 2023
3 citations
1028 days after retraction
Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
Mehrdad Izadirad, Leila Jafari, Alva Rani James et al. (6 authors)
Drug Discovery Today
Published: Mar 2021
26 citations
54 days after retraction
Application of Nursing Intervention Guided by King’s Interactive Standard Theory in Patients with Lumbar Disc Herniation Undergoing Conservative Treatment
Wang Fu, Ying Li
Indian Journal of Pharmaceutical Sciences Open Access
Published: Jan 2021
1 citation
31 days before retraction
LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15
Wenli Zuo, Keshu Zhou, Mei Deng et al. (8 authors)
Aging Open Access
Published: Oct 2020
17 citations
120 days before retraction
<scp>lncRNA ZEB2‐AS1</scp>: A promising biomarker in human cancers
Mahboobeh Zarei, Pegah Mousavi, Fatemeh Sadri et al. (7 authors)
IUBMB Life Open Access
Published: Jul 2020
21 citations
196 days before retraction